8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
May 1, 2026·SEC
Material company update
Mar 20, 2026·SEC
7.125% Fixed-Rate Reset Subordinated Debentures due 2052(RZC)Earnings, Financials & Key Ratios
RZC•NYSE•Insurance & Managed Care
1.5× P/E·Price updated Jun 19, 2026
AboutReinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. It operates through the following segments: U.S. and Latin America, Canada, Europe, Middle East, and Africa, Asia Pacific, and Corporate and Other. The U.S. and Latin America segment markets individual and group life and health reinsurance to domestic clients for a variety of products through yearly renewable term agreements, coinsurance, and modified coinsurance. The Canada segment offers individual life reinsurance, and, to a lesser extent, creditor, group life and health, critical illness, and disability reinsurance, through yearly renewable term and coinsurance agreements. The Europe, Middle East, and Africa segment serves individual and group life and health products through yearly renewable term and coinsurance agreements, reinsurance of critical illness coverage that provides a benefit in the event of the diagnosis of a pre-defined critical illness, and underwritten annuities. The Asia Pacific segment consists of individual and group life and health reinsurance, critical illness coverage, disability, and superannuation through yearly renewable term and coinsurance agreements. The Corporate and Other segment consists of investment income from unallocated invested assets, investment related gains, and losses and service fees. The company was founded in 1973 and is headquartered in Chesterfield, MO.Show more
- Revenue$22.79B+3.4%
- Combined Ratio93.24%-2.4%
- Net Income$1.18B+64.9%
- Return on Equity9.67%+35.3%
- Medical Cost Ratio74.6%-15.9%
- Operating Margin6.76%+52.0%
- Net Margin5.19%+59.4%
- ROA0.86%+29.5%
- Equity / Assets8.65%-5.8%
RZC Key Insights
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 93.2% combined ratio
- ✓Strong 5Y profit CAGR of 23.3%
- ✓Strong Piotroski F-Score: 7/9
- ✓Trading near 52-week high
- ✓Trading at only 0.1x book value
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when RZC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
RZC Price & Volume
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) stock price & volume — 10-year historical chart
Loading chart...
RZC Growth Metrics
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years8.14%
5 Years9.34%
3 Years12.8%
TTM-13.55%
Profit CAGR
10 Years8.94%
5 Years23.29%
3 Years31.74%
TTM13.03%
EPS CAGR
10 Years9.02%
5 Years22.9%
3 Years32.3%
TTM13.5%
Return on Capital
10 Years1.33%
5 Years1.13%
3 Years1.1%
Last Year1.12%
RZC Recent Earnings
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) EPS & revenue vs analyst estimates — last 4 quarters
Q2 2026Latest
May 7, 2026Metric
Actual
Est
EPS
$6.97
—
Rev
—
—
Q1 2026
Feb 5, 2026Metric
Actual
Est
EPS
$7.75
—
Rev
$6.6B
—
Q1 2024
Feb 1, 2024Metric
Actual
Est
EPS
$4.73
—
Rev
$5.0B
—
Q4 2023
Nov 2, 2023Metric
Actual
Est
EPS
$5.57
—
Rev
—
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $6.97 | — |
| Q1 2026 | Feb 5, 2026 | $7.75 | $6.6B |
| Q1 2024 | Feb 1, 2024 | $4.73 | $5.0B |
| Q4 2023 | Nov 2, 2023 | $5.57 | — |
Based on last 8 quarters of dataView full earnings history →
RZC Peer Comparison
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) competitors in Reinsurance (P&C and life) — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 GS | 348.27B | 1096.56 | 21.37 | -1.38% | 13.73% | 13.58% | 4.88 | |
 MS | 355.51B | 223.17 | 21.88 | 11.48% | 14.66% | 15.3% | 4.22 | |
 JEF | 13.83B | 62.10 | 21.94 | 2.93% | 6.56% | 6.8% | 2.23 | |
 LAZ | 4.16B | 44.30 | 20.41 | 3.25% | 7.5% | 26.7% | 2.61 | |
 HLI | 9.82B | 140.77 | 24.19 | 24.81% | 16.91% | 20.14% | 0.20 | |
 MC | 4.93B | 67.18 | 22.85 | 26.98% | 15.36% | 37.88% | 0.39 | |
 PJT | 3.76B | 155.47 | 23.27 | 14.77% | 10.32% | 20.08% | 0.41 | |
 OXSQ | 117.26M | 1.34 | -5.36 | 32.01% | -24.71% | 1.08 |
Compare RZC vs Peers
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
RZC Income Statement
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 12.52B | 12.88B | 14.2B | 14.58B | 16.06B | 15.88B | 18.39B | 22.04B | 22.79B | 18.13B |
Revenue Growth % | 8.63% | 2.88% | 10.27% | 2.71% | 10.13% | -1.13% | 15.82% | 19.85% | 3.39% | -13.55% |
Medical Costs & Claims | 10.49B | 11.07B | 12.1B | 13.04B | 14.21B | 14.31B | 16.06B | 19.55B | 17B | 14.97B |
Medical Cost Ratio % | 83.8% | 85.95% | 85.2% | 89.41% | 88.46% | 90.11% | 87.33% | 88.71% | 74.6% | 82.6% |
Gross Profit | 2.03B▲ 0% | 1.81B▼ 10.8% | 2.1B▲ 16.1% | 1.54B▼ 26.5% | 1.85B▲ 20.1% | 1.57B▼ 15.3% | 2.33B▲ 48.4% | 2.49B▲ 6.7% | 5.79B▲ 132.6% | 3.15B▲ 0% |
Gross Margin % | 16.2% | 14.05% | 14.8% | 10.59% | 11.54% | 9.89% | 12.67% | 11.29% | 25.4% | 17.37% |
Gross Profit Growth % | 9.45% | -10.8% | 16.14% | -26.51% | 20.08% | -15.26% | 48.38% | 6.74% | 132.64% | - |
Operating Expenses | 885M | 963M | 969M | 991M | 469M | 853M | 1.17B | 1.51B | 4.25B | 1.98B |
OpEx / Revenue % | 7.07% | 7.48% | 6.82% | 6.8% | 2.92% | 5.37% | 6.37% | 6.84% | 18.64% | 10.91% |
Depreciation & Amortization | 53M | 45M | 49M | 49M | 43M | 38M | 41M | 46M | 43M | 0 |
Combined Ratio % | 90.87% | 93.43% | 92.03% | 96.21% | 91.38% | 95.48% | 93.69% | 95.55% | 93.24% | 93.5% |
Operating Income | 1.14B▲ 0% | 846M▼ 26.0% | 1.13B▲ 33.8% | 553M▼ 51.1% | 1.39B▲ 150.5% | 718M▼ 48.2% | 1.16B▲ 61.6% | 980M▼ 15.5% | 1.54B▲ 57.1% | 1.17B▲ 0% |
Operating Margin % | 9.13% | 6.57% | 7.97% | 3.79% | 8.62% | 4.52% | 6.31% | 4.45% | 6.76% | 6.46% |
Operating Income Growth % | 9.49% | -25.98% | 33.81% | -51.15% | 150.45% | -48.16% | 61.56% | -15.52% | 57.14% | - |
EBITDA | 1.2B | 891M | 1.18B | 602M | 1.43B | 756M | 1.2B | 1.03B | 1.58B | 1.46B |
EBITDA Margin % | 9.56% | 6.92% | 8.32% | 4.13% | 8.89% | 4.76% | 6.53% | 4.65% | 6.95% | 8.04% |
Interest Expense | 146M | 147M | 173M | 170M | 139M | 191M | 257M | 304M | 366M | 286.1M |
Non-Operating Income | -146M | -147M | -173M | -170M | -139M | -191M | -257M | -304M | -366M | -286M |
Pretax Income | 1.14B▲ 0% | 846M▼ 26.0% | 1.13B▲ 33.8% | 553M▼ 51.1% | 1.39B▲ 150.5% | 718M▼ 48.2% | 1.16B▲ 61.6% | 980M▼ 15.5% | 1.54B▲ 57.1% | 1.17B▲ 0% |
Pretax Margin % | 9.13% | 6.57% | 7.97% | 3.79% | 8.62% | 4.52% | 6.31% | 4.45% | 6.76% | 6.46% |
Income Tax | -679M | 130M | 262M | 138M | 215M | 197M | 251M | 256M | 351M | 270.11M |
Effective Tax Rate % | -59.41% | 15.37% | 23.14% | 24.95% | 15.52% | 27.44% | 21.64% | 26.12% | 22.79% | 23.06% |
Net Income | 1.82B▲ 0% | 716M▼ 60.7% | 870M▲ 21.5% | 415M▼ 52.3% | 1.17B▲ 181.9% | 517M▼ 55.8% | 902M▲ 74.5% | 717M▼ 20.5% | 1.18B▲ 64.9% | 896.33M▲ 0% |
Net Margin % | 14.56% | 5.56% | 6.13% | 2.85% | 7.28% | 3.26% | 4.9% | 3.25% | 5.19% | 4.94% |
Net Income Growth % | 159.75% | -60.7% | 21.51% | -52.3% | 181.93% | -55.81% | 74.47% | -20.51% | 64.85% | 13.03% |
EPS (Diluted) | 27.71▲ 0% | 11.00▼ 60.3% | 13.62▲ 23.8% | 6.31▼ 53.7% | 9.04▲ 43.3% | 7.64▼ 15.5% | 13.44▲ 75.9% | 10.73▼ 20.2% | 17.69▲ 64.9% | -▲ 0% |
EPS Growth % | 156.81% | -60.3% | 23.82% | -53.67% | 43.26% | -15.49% | 75.92% | -20.16% | 64.86% | 13.5% |
EPS (Basic) | 28.28 | 11.25 | 13.88 | 6.35 | 9.10 | 7.73 | 13.60 | 10.90 | 17.94 | - |
Diluted Shares Outstanding | 65.75M | 65.09M | 63.88M | 65.8M | 68.3M | 67.7M | 67.1M | 66.9M | 66.73M | 0 |
RZC Balance Sheet
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 60.51B | 64.54B | 76.73B | 84.66B | 92.17B | 84.9B | 97.62B | 118.67B | 156.59B | 164.06B |
Asset Growth % | 13.97% | 6.64% | 18.9% | 10.33% | 8.88% | -7.89% | 14.98% | 21.56% | 31.95% | 107.78% |
Total Investment Assets | 51.69B | 54.21B | 66.56B | 72.4B | 78.53B | 70.48B | 78.9B | 98.04B | 130.48B | 4M |
Long-Term Investments | 51.69B | 54.21B | 66.56B | 72.4B | 78.53B | 70.48B | 78.9B | 98.04B | 130.48B | 367.99B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 107.33B |
Total Current Assets | 3.64B | 4.91B | 4.39B | 6.25B | 5.84B | 5.94B | 6.5B | 7.22B | 8.64B | 112.32B |
Cash & Equivalents | 1.3B | 1.89B | 1.45B | 3.41B | 2.95B | 2.93B | 2.97B | 3.33B | 4.17B | 4.99B |
Receivables | 2.34B | 3.02B | 2.94B | 2.84B | 2.89B | 3.01B | 3.53B | 3.9B | 4.47B | 12.71B |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill & Intangibles | 204.8M | 40M | 33M | 25M | 12M | 14M | 11M | 8M | 6M | 6M |
Goodwill | 7M | 7M | 7M | 7M | 7M | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 197.8M | 33M | 26M | 18M | 5M | 14M | 11M | 8M | 6M | 0 |
PP&E (Net) | 302.2M | 302.1M | 296M | 291M | 284M | 408M | 416M | 450M | 480M | 0 |
Other Assets | 4.67B | 5.08B | 5.46B | 5.69B | 7.51B | 8.06B | 11.8B | 12.95B | 16.98B | 0 |
Total Liabilities | 50.95B | 56.08B | 65.13B | 70.3B | 79.16B | 77.73B | 88.45B | 107.77B | 143.04B | 150.68B |
Total Debt | 3.57B | 3.47B | 3.58B | 3.96B | 3.85B | 3.96B | 4.43B | 5.04B | 5.71B | 6.11B |
Net Debt | 2.27B | 1.58B | 2.13B | 553M | 899M | 1.03B | 1.46B | 1.72B | 1.54B | 1.11B |
Long-Term Debt | 3.57B | 3.47B | 3.58B | 3.96B | 3.85B | 3.96B | 4.43B | 5.04B | 5.71B | 6.11B |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.18B |
Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.18B |
Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 8.04B |
Other Liabilities | 45.17B | 50.82B | 58.84B | 63.08B | 72.43B | 72.39B | 82.16B | 100.53B | 134.33B | 141.39B |
Total Equity | 9.57B▲ 0% | 8.45B▼ 11.7% | 11.6B▲ 37.3% | 14.35B▲ 23.7% | 13.01B▼ 9.3% | 7.17B▼ 44.9% | 9.17B▲ 27.9% | 10.91B▲ 18.9% | 13.55B▲ 24.3% | 13.38B▲ 0% |
Equity Growth % | 34.91% | -11.69% | 37.28% | 23.71% | -9.32% | -44.9% | 27.89% | 18.92% | 24.25% | 80.81% |
Shareholders Equity | 9.57B | 8.45B | 11.6B | 14.35B | 13.01B | 7.08B | 9.08B | 10.82B | 13.46B | 13.29B |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 90M | 90M | 90M | 90M | 90M |
Retained Earnings | 6.74B | 7.28B | 7.95B | 8.15B | 8.56B | 8.17B | 8.8B | 9.26B | 10.15B | 10.38B |
Common Stock | 791K | 791K | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
Accumulated OCI | 2.06B | 636.76M | 3.14B | 5.36B | 3.64B | -1.87B | -369M | 849M | 2.68B | 2.31B |
Return on Equity (ROE) | 21.87% | 7.95% | 8.68% | 3.2% | 8.55% | 5.12% | 11.04% | 7.14% | 9.67% | 6.88% |
Return on Assets (ROA) | 3.21% | 1.15% | 1.23% | 0.51% | 1.32% | 0.58% | 0.99% | 0.66% | 0.86% | 0.59% |
Equity / Assets | 15.81% | 13.09% | 15.12% | 16.95% | 14.12% | 8.45% | 9.39% | 9.19% | 8.65% | 8.16% |
Debt / Equity | 0.37x | 0.41x | 0.31x | 0.28x | 0.30x | 0.55x | 0.48x | 0.46x | 0.42x | 0.46x |
Book Value per Share | 145.54 | 129.82 | 181.60 | 218.12 | 190.54 | 105.92 | 136.68 | 163.02 | 203.07 | - |
Tangible BV per Share | 142.42 | 129.21 | 181.08 | 217.74 | 190.37 | 105.72 | 136.51 | 162.90 | 202.98 | - |
RZC Cash Flow Statement
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.98B | 1.58B | 2.31B | 3.32B | 4.18B | 1.34B | 4.04B | 9.37B | 4.09B | 5.54B |
Operating CF Growth % | 35.24% | -20.24% | 45.91% | 44% | 25.89% | -67.89% | 201.12% | 131.7% | -56.34% | 31.88% |
Operating CF / Revenue % | 15.84% | 12.28% | 16.25% | 22.78% | 26.04% | 8.46% | 21.99% | 42.51% | 17.95% | 30.53% |
Net Income | 1.82B | 715.84M | 870M | 415M | 617M | 517M | 902M | 717M | 1.18B | 896.33M |
Depreciation & Amortization | 53M | 45.13M | 49M | 3M | -11M | 38M | 41M | 46M | 43M | 0 |
Stock-Based Compensation | 0 | 0 | 39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | 0 | 76.51M | 0 | -16M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -249.14M | 5.38M | -31M | -62M | -731M | 346M | -34M | 343M | -301M | 4.6B |
Working Capital Changes | 356.27M | 738.26M | 1.38B | 2.98B | 4.31B | 442M | 3.13B | 8.26B | 3.17B | 0 |
Cash from Investing | -1.61B | -636.55M | -2.64B | -2.68B | -4.63B | -5.69B | -4.07B | -12.54B | -12.09B | -14.1B |
Capital Expenditures | -44.21M | -28.89M | -34M | -28M | -19M | -25M | 0 | 0 | 0 | 0 |
Acquisitions | 0 | -31.44M | 4M | -173M | -287M | 17M | -77M | -320M | 0 | 0 |
Purchase of Investments | -8.94B | -10.1B | -16.28B | -10.26B | -18.28B | -17.07B | -13.25B | -41.69B | -43.67B | -47.4B |
Sale/Maturity of Investments | 8.04B | 10.14B | 14.11B | 7.67B | 13.83B | 11.47B | 8.55B | 30.49B | 32.19B | 33.98B |
Other Investing | -657.07M | -615.69M | -442M | 115M | 129M | -77M | 711M | -1.03B | -613M | -678M |
Cash from Financing | -324.62M | -321.97M | -121M | 1.25B | 20M | 4.44B | 78M | 3.66B | 8.8B | 8.4B |
Dividends Paid | -117.29M | -140.11M | -163M | -182M | -194M | -205M | -219M | -229M | -240M | -242M |
Share Repurchases | -44M | -299.68M | -101M | -163M | -99M | -81M | -227M | -27M | -174M | -230M |
Stock Issued | 0 | 0 | 0 | 481M | 0 | 0 | 0 | 0 | 4M | 4M |
Debt Issuance (Net) | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | -3M |
Other Financing | 207.67M | 217.14M | 38M | 737M | 430M | 4.62B | 62M | 3.31B | 8.55B | 8.8B |
Net Change in Cash | 102.81M▲ 0% | 586.21M▲ 470.2% | -441M▼ 175.2% | 1.96B▲ 544.2% | -460M▼ 123.5% | -21M▲ 95.4% | 43M▲ 304.8% | 356M▲ 727.9% | 842M▲ 136.5% | -158M▲ 0% |
Exchange Rate Effect | 52.69M | -36.39M | 11M | 63M | -34M | -112M | -13M | -130M | 47M | 6M |
Cash at Beginning | 1.2B | 1.3B | 1.89B | 1.45B | 3.41B | 2.95B | 2.93B | 2.97B | 3.33B | 4.17B |
Cash at End | 1.3B | 1.89B | 1.45B | 3.41B | 2.95B | 2.93B | 2.97B | 3.33B | 4.17B | 4.99B |
Free Cash Flow | 1.94B▲ 0% | 1.55B▼ 19.9% | 2.27B▲ 46.4% | 3.29B▲ 44.9% | 4.16B▲ 26.4% | 1.32B▼ 68.3% | 4.04B▲ 206.8% | 9.37B▲ 131.7% | 4.09B▼ 56.3% | 5.54B▲ 0% |
FCF Growth % | 36.38% | -19.91% | 46.43% | 44.92% | 26.38% | -68.34% | 206.83% | 131.7% | -56.34% | 9.32% |
FCF Margin % | 15.48% | 12.06% | 16.01% | 22.59% | 25.92% | 8.3% | 21.99% | 42.51% | 17.95% | 30.53% |
FCF per Share | 29.48 | 23.85 | 35.58 | 50.06 | 60.95 | 19.47 | 60.27 | 140.06 | 61.31 | - |
RZC Key Ratios
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 90.87% | 93.43% | 92.03% | 96.21% | 91.38% | 95.48% | 93.69% | 95.55% | 93.24% | 93.5% |
Medical Cost Ratio | 83.8% | 85.95% | 85.2% | 89.41% | 88.46% | 90.11% | 87.33% | 88.71% | 74.6% | 82.6% |
Return on Equity (ROE) | 21.87% | 7.95% | 8.68% | 3.2% | 8.55% | 5.12% | 11.04% | 7.14% | 9.67% | 6.88% |
Return on Assets (ROA) | 3.21% | 1.15% | 1.23% | 0.51% | 1.32% | 0.58% | 0.99% | 0.66% | 0.86% | 0.59% |
Equity / Assets | 15.81% | 13.09% | 15.12% | 16.95% | 14.12% | 8.45% | 9.39% | 9.19% | 8.65% | 8.16% |
Book Value / Share | 145.54 | 129.82 | 181.6 | 218.12 | 190.54 | 105.92 | 136.68 | 163.02 | 203.07 | - |
Debt / Equity | 0.37x | 0.41x | 0.31x | 0.28x | 0.30x | 0.55x | 0.48x | 0.46x | 0.42x | 0.46x |
Revenue Growth | 8.63% | 2.88% | 10.27% | 2.71% | 10.13% | -1.13% | 15.82% | 19.85% | 3.39% | -13.55% |
Related:RZC Dividend History·RZC Revenue History·RZC Price History·RZC P/E History·RZC Financial Ratios·RZC Institutional Holders
RZC SEC Filings & Documents
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) SEC filings — annual & quarterly reports (10-K, 10-Q)
RZC Frequently Asked Questions
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) grew revenue by 3.4% over the past year. Growth has been modest.
Yes, 7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) is profitable, generating $896.3M in net income for fiscal year 2025 (5.2% net margin).
Dividend & Returns
Yes, 7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) pays a dividend with a yield of 13.99%. This makes it attractive for income-focused investors.
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) has a return on equity (ROE) of 9.7%. This is below average, suggesting room for improvement.
Industry Metrics
7.125% Fixed-Rate Reset Subordinated Debentures due 2052 (RZC) has a combined ratio of 93.2%. A ratio below 100% indicates underwriting profitability.